Citing steady and stable management team, positive operating performance pre-pandemic, solid vision and execution of merger strategy, improvement of quality and good balance sheet management, S&P Global Ratings reasserts Ballad Health’s “A-” rating with a stable outlook
Citing steady and stable management team, positive operating performance pre-pandemic, solid vision and execution of merger strategy, improvement of quality and good balance sheet management, S&P Global Ratings reasserts Ballad Health’s “A-” rating with a stable outlook